ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Xaira Therapeutics built X-Cell, a model trained on the X-Atlas CRISPR dataset of causal gene-expression data. The 3.1B parameter model fell off scaling trends on smaller data. X-Atlas provides roughly 30x more information, enabling scaling with parameters and compute for predicting drug-induced gene expression changes.
Tap to vote and see what everyone thinks.
Summary by ByteBrief